Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1973 1
1974 4
1975 1
1976 1
1977 2
1978 2
1979 2
1980 1
1981 1
1982 4
1983 3
1984 12
1985 5
1986 4
1987 11
1988 4
1989 3
1990 9
1991 10
1992 8
1993 5
1994 6
1995 2
1996 10
1997 9
1998 4
1999 9
2000 8
2001 13
2002 10
2003 9
2004 9
2005 8
2006 11
2007 7
2008 6
2009 6
2010 9
2011 3
2012 6
2013 7
2014 5
2015 5
2016 4
2017 6
2018 10
2019 4
2020 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Results by year

Filters applied: . Clear all
Page 1
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data.
Thomalla G, Boutitie F, Ma H, Koga M, Ringleb P, Schwamm LH, Wu O, Bendszus M, Bladin CF, Campbell BCV, Cheng B, Churilov L, Ebinger M, Endres M, Fiebach JB, Fukuda-Doi M, Inoue M, Kleinig TJ, Latour LL, Lemmens R, Levi CR, Leys D, Miwa K, Molina CA, Muir KW, Nighoghossian N, Parsons MW, Pedraza S, Schellinger PD, Schwab S, Simonsen CZ, Song SS, Thijs V, Toni D, Hsu CY, Wahlgren N, Yamamoto H, Yassi N, Yoshimura S, Warach S, Hacke W, Toyoda K, Donnan GA, Davis SM, Gerloff C; Evaluation of unknown Onset Stroke thrombolysis trials (EOS) investigators. Thomalla G, et al. Lancet. 2020 Nov 14;396(10262):1574-1584. doi: 10.1016/S0140-6736(20)32163-2. Epub 2020 Nov 8. Lancet. 2020. PMID: 33176180 Free PMC article.
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group; Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Lees KR, et al. Lancet. 2010 May 15;375(9727):1695-703. doi: 10.1016/S0140-6736(10)60491-6. Lancet. 2010. PMID: 20472172
SUMO and ischemic tolerance.
Lee YJ, Hallenbeck JM. Lee YJ, et al. Among authors: hallenbeck jm. Neuromolecular Med. 2013 Dec;15(4):771-81. doi: 10.1007/s12017-013-8239-9. Epub 2013 Jun 18. Neuromolecular Med. 2013. PMID: 23775726 Review.
Neuronal regeneration after stroke.
Nadareishvili Z, Hallenbeck J. Nadareishvili Z, et al. Among authors: hallenbeck j. N Engl J Med. 2003 Jun 5;348(23):2355-6. doi: 10.1056/NEJMcibr023192. N Engl J Med. 2003. PMID: 12789002 Review. No abstract available.
SUMOylation in brain ischemia: Patterns, targets, and translational implications.
Bernstock JD, Yang W, Ye DG, Shen Y, Pluchino S, Lee YJ, Hallenbeck JM, Paschen W. Bernstock JD, et al. Among authors: hallenbeck jm. J Cereb Blood Flow Metab. 2018 Jan;38(1):5-16. doi: 10.1177/0271678X17742260. Epub 2017 Nov 17. J Cereb Blood Flow Metab. 2018. PMID: 29148315 Free PMC article. Review.
Doctor and friend.
Hallenbeck J. Hallenbeck J. Virtual Mentor. 2005 Jun 1;7(6):virtualmentor.2005.7.6.ccas2-0506. doi: 10.1001/virtualmentor.2005.7.6.ccas2-0506. Virtual Mentor. 2005. PMID: 23253456 Free article. No abstract available.
ACSP Distinguished Educator, 2015: Leonie Sandercock.
Hallenbeck J. Hallenbeck J. J Plan Educ Res. 2022 Dec;42(4):704-706. doi: 10.1177/0739456X221125740. Epub 2022 Oct 11. J Plan Educ Res. 2022. PMID: 36397984 Free PMC article. No abstract available.
Ischemic tolerance and endogenous neuroprotection.
Dirnagl U, Simon RP, Hallenbeck JM. Dirnagl U, et al. Among authors: hallenbeck jm. Trends Neurosci. 2003 May;26(5):248-54. doi: 10.1016/S0166-2236(03)00071-7. Trends Neurosci. 2003. PMID: 12744841 Review.
Quantitative high-throughput screening identifies cytoprotective molecules that enhance SUMO conjugation via the inhibition of SUMO-specific protease (SENP)2.
Bernstock JD, Ye D, Smith JA, Lee YJ, Gessler FA, Yasgar A, Kouznetsova J, Jadhav A, Wang Z, Pluchino S, Zheng W, Simeonov A, Hallenbeck JM, Yang W. Bernstock JD, et al. Among authors: hallenbeck jm. FASEB J. 2018 Mar;32(3):1677-1691. doi: 10.1096/fj.201700711R. Epub 2018 Jan 3. FASEB J. 2018. PMID: 29146736 Free PMC article.
270 results